Charles River Laboratories International CRL
NYSE CRL
$277.86 -3.81 (-1.35%)
As of: Sep 18, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) FCF Margin Growth (1y) (2010 - 2026)

Analysis

Charles River Laboratories International (CRL) FCF Margin Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (1y) (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 97.00
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn -408.00
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 693.00
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn -160.00
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 92.00
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -12,969.00
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -629.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn 3,881.00
10 VivoSim Labs 1.37 Mn 1.37 Mn - -732,913.00
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 -160.00
Mar 28, 2026 -1,291.00
Dec 27, 2025 -246.00
Sep 27, 2025 -336.00
Jun 28, 2025 139.00
Mar 29, 2025 640.00
Dec 28, 2024 -572.00
Sep 28, 2024 751.00
Jun 29, 2024 740.00
Mar 30, 2024 477.00
Dec 30, 2023 82.00
Sep 30, 2023 748.00
Jul 1, 2023 77.00
Apr 1, 2023 -218.00
Dec 31, 2022 -117.00
Sep 24, 2022 -720.00
Jun 25, 2022 -848.00
Mar 26, 2022 -1,482.00
Dec 25, 2021 803.00
Sep 25, 2021 -703.00